Klinikum der Philipps Universitat Marburg

Marburg 35043

0 studies enrolling now · 2 studies all time

What they study most

Hormone Refractory Prostate Cancer, Multiple Sclerosis, Prostate Cancer

Studies at this site

• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed